Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06640803 · ClinicalTrials.gov registry record · NA

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

A NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
223
Enrollment target
6
Study locations

NCT06640803 is a NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 223 participants. The trial reports 6 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06640803, a NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
223 participants
Enrollment target
6
Study locations

Study Summary

This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers.

Interventions

  • BEHAVIORAL Stepped-Care including Cognitive Behavioral Case Management

Study Locations (6)

California

  • River Oak Center for Children - Elk Grove
  • Turning Point Community Programs - Elk Grove
  • University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs - Sacramento
  • University of California-Davis CAARE Diagnostic and Treatment Center - Sacramento
  • Capital Star Community Services - Sacramento
  • Heartland Child and Family Services - Sacramento

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2023-03-20
Est. Completion 2026-10-01
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT06640803

The ClinicalTrials.gov registry entry for NCT06640803 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Clinical High Risk for Psychosis appearing as the primary indexed condition, and to 1 intervention - of which Stepped-Care including Cognitive Behavioral Case Management is the first listed.

NCT06640803 reports 6 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06640803 about?

NCT06640803 is a clinical study titled "Sacramento Clinical High Risk for Psychosis Stepped-Care Program". This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers.

What is the current status of trial NCT06640803?

This trial is currently recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2023-03-20. Estimated completion is 2026-10-01.

What conditions does trial NCT06640803 study?

This clinical trial studies the following conditions: Clinical High Risk for Psychosis, Ultra High Risk for Psychosis.

What interventions are being tested in trial NCT06640803?

The interventions under investigation include: Stepped-Care including Cognitive Behavioral Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT06640803?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06640803 being conducted?

This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Clinical High Risk for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.